SAT-140 Predictive value of systemic inflammation biomarkers towards recompensation versus progression to further decompensation in patients with decompensated cirrhosis
Dalila Costa(Hospital Braga), Thomas Reiberger(ERN GUARD-Heart), Benedikt Simbrunner(Austrian Academy of Sciences), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Georg Semmler(University of Southern Denmark), Carla Rolanda, Benedikt Hofer(Austrian Academy of Sciences), Joana Camões Neves(Hospital Braga), Georg Kramer(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), A. M. Frias, Mattias Mandorfer(Medical University of Vienna), João Belmiro, Ricardo Silvestre(United Nations University)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119